J. Byrne

发表

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

P. Read, B. Conway, M. Hellard, 2018, The lancet. Gastroenterology & hepatology.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

M. Hellard, G. Dore, L. Taylor, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection.

M. Hellard, G. Dore, L. Taylor, 2015, The International journal on drug policy.

Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership

A. Corry, Graham Brown, J. Byrne, 2019, Harm Reduction Journal.

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.

C. Stedman, P. Read, B. Conway, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients

S. Nielsen, B. Larance, L. Degenhardt, 2022, Drug and alcohol review.

Human rights and access to hepatitis C treatment for people who inject drugs.

N. Luhmann, D. Wolfe, M. Harris, 2015, The International journal on drug policy.

Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs.

T. Rhodes, G. Dore, C. Treloar, 2015, The International journal on drug policy.

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

G. Dore, L. Taylor, B. Haire, 2015, Journal of hepatology.

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

J. Lazarus, M. Hellard, G. Dore, 2017, The International journal on drug policy.

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

J. Lazarus, M. Hellard, J. Dillon, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study

P. Read, G. Dore, M. Weltman, 2019, Journal of viral hepatitis.

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study.

G. Dore, T. Collie, M. Micallef, 2015, The International journal on drug policy.

Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.

T. Rhodes, G. Dore, C. Treloar, 2015, The International journal on drug policy.

Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination.

R. Lobo, C. Henderson, J. Byrne, 2019, The International journal on drug policy.

COVID‐19 vaccination among people who inject drugs: Leaving no one behind

A. Dunlop, L. Maher, A. Peacock, 2021, Drug and alcohol review.

Harm reduction - a historical view from the left.

S. Friedman, N. Crofts, J. Byrne, 2001, The International journal on drug policy.

Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs.

E. Cama, C. Treloar, L. Brener, 2021, The International journal on drug policy.

Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study

P. Read, B. Conway, M. Hellard, 2017 .

Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia.

L. Maher, J. Iversen, J. Byrne, 2010, Drug and alcohol review.

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

J. Lazarus, M. Hellard, G. Dore, 2017, The International journal on drug policy.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

M. Hellard, J. Grebely, P. Bruggmann, 2015, The International journal on drug policy.

Information acquisition and dissemination among a sample of people who inject drugs in Australia.

A. Peacock, R. Sutherland, J. Byrne, 2023, Drug and Alcohol Review.

Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences.

E. Albert, J. Byrne, 2010, The International journal on drug policy.